Question 1

What is Ranibizumab used for?

Accepted Answer

Ranibizumab (brand name Lucentis) is a Anti-VEGF (Ophthalmology) indicated for Wet AMD, DME, RVO.

Question 2

How does Ranibizumab work?

Accepted Answer

Ranibizumab works through the following mechanism: Humanized monoclonal antibody fragment that binds and inhibits all active forms of VEGF-A..

Question 3

What are the most common side effects of Ranibizumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Ranibizumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Ranibizumab the same as Lucentis?

Accepted Answer

Lucentis is a brand name for Ranibizumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Ranibizumab

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations